{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:53Z","timestamp":1790808233495,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejvs.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T01:08:18Z","timestamp":1627434498000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Editor's Choice \u2013 External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry"],"prefix":"10.1016","volume":"62","author":[{"given":"Fran\u00e7ois-Xavier","family":"Lap\u00e9bie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Boulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Messas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ferri\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Bongard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bura-Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2021.05.028_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jvs.2017.01.067","article-title":"Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: results from a Swedish nationwide study","volume":"66","author":"Sigvant","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.05.028_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.05.028_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.05.028_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2021.05.028_bib5","first-page":"e686","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2021.05.028_bib6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2021.05.028_bib7","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2021.05.028_bib8","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2021.05.028_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A\u00a0literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.ejvs.2021.05.028_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jvs.2019.01.052","article-title":"Why randomized controlled trials do not always reflect reality","volume":"70","author":"Paraskevas","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.05.028_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejvs.2010.02.009","article-title":"Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry","volume":"39","author":"Cambou","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.05.028_bib12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nmeth.2659","article-title":"Points of significance: error bars","volume":"10","author":"Krzywinski","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.ejvs.2021.05.028_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl. 102","key":"10.1016\/j.ejvs.2021.05.028_bib14","first-page":"1","article-title":"ESVM Guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2021.05.028_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2021.05.028_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ahj.2020.01.015","volume":"222","author":"Fox","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejvs.2021.05.028_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clinthera.2020.03.006","article-title":"Use of real-world data for new\u00a0drug applications and line extensions","volume":"42","author":"Bolislis","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejvs.2021.05.028_bib18","article-title":"External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry","volume":"39","author":"Darmon","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2021.05.028_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ehjcvp\/pvz013","article-title":"External applicability of the COMPASS trial: the Western Denmark Heart Registry","volume":"5","author":"W\u00fcrtz","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ejvs.2021.05.028_bib20","first-page":"460","article-title":"Assessment of patients with coronary artery disease who may benefit from the use of rivaroxaban in the real world: implementation of the COMPASS trial criteria in the TERCET registry population","volume":"129","author":"Desperak","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.ejvs.2021.05.028_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.repc.2020.02.012","article-title":"Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome","volume":"39","author":"Faria","year":"2020","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.ejvs.2021.05.028_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.11.138","article-title":"The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: the COMPASS criteria applied to a post-MI population","volume":"278","author":"Schiele","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejvs.2021.05.028_bib23","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.05.028_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejvs.2019.09.006","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia","volume":"59","author":"Bj\u00f6rck","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421004445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421004445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:56:20Z","timestamp":1761047780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588421004445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1078588421004445"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.05.028","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}